Danbury pharmaceutical company 'unlocks' $100 million in sale-leaseback deal for manufacturing plant
A drugmaker has struck a $100 million deal to sell and lease back its 260,000-square-foot...
Source: trumbulltimes.com
Page 2 - Afrezza News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Afrezza. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Afrezza Today - Breaking & Trending Today
Afrezza Quarterly Sales Increase, New Therapies on Horizon at MannKind | San Fernando Valley Business Journal
MannKind Corp. touted increased sales for its flagship drug Afrezza during its fourth quarter earnings report on Thursday, while pointing out its new direction toward therapies for lung and endocrine diseases. During the quarter, MannKind pulled in $10.1 million in revenue for Afrezza, its inhalable insulin, a 30 percent increase compared to sales in the same quarter of 2019. The Westlake Village biotech company reported an adjusted net loss of $13.2 million (-6 cents a share). That’s narrower than the net loss of $14.3 million (-7 cents) in the same period a year earlier. Revenue was $18.4...
Source: sfvbj.com
Detailed text transcripts for TV channel - KNTV - 20140628:00:51:30
Latest updates on this topic from reliable sources.
Source: news source